Latest News: Veeda Clinical raises $16 mn from Sabre Partners Veeda Clinical Research acquires a majority stake in Bioneeds

Biologics & Biosimilars

Biologics & Biosimilars

Veeda and Somru BioScience announced the launch of their premier global centre of excellence lab under the flagship of Ingenuity BioSciences Pvt. Ltd.

The Board of Directors of both companies have made a strategic alliance to expand their specialized service offerings, complementing their well-established portfolio in clinical services and bioassay kit development

Why Veeda?

  • Veeda is an Independent Indian CRO with 16 years of experience.
  • Veeda has conducted over 3400+ studies & has worked with over 200 (Bio) pharmaceutical companies around the world.
  • Veeda has an exemplary regulatory record of successfully completingaudits of USFDA, AGES, MHRA, ANVISA, WHO, NPA, ANSM, MCC, DCGI & NPRA
  • Due to stringent quality norms and transparency at all stages, Veeda is considered to be a preferred partner for many (Bio) Pharmaceutical companies
  • Veeda’s has a vast experience in scientific and regulatory compliant protocol designing that enables the drug development process of Early to Late phase clinical trials
  • Veeda has over 600+ analytical methods & 60+ NCE molecules developed and validated so far
  • Veeda ensures study specific clinical safety measures for all subjects through risk mitigation strategies
  • Veeda has Quality Management System in place to capture any non-compliance or deviation identified during the study with an effective mechanism of corrective and preventive actions implemented

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.